Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis-Reference-Cited by-同舟云学术

Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis

Published:2023-03-28 Issue:3 Volume:45 Page:689-697
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Cao Mingnan,Pan Chen,Tian Yue,Wang Li,Zhao Zhigang^ORCID,Zhu Bin

Funder

Clinical Toxicology Project of Chinese Society of Toxicology

Digestive Medical Coordinated Development Center of Beijing Hospitals Authority

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-023-01556-2.pdf

Reference39 articles.

1. Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012;8(12):728–42.

2. Tian L, Jin T. The incretin hormone GLP-1 and mechanisms underlying its secretion. J Diabetes. 2016;8(6):753–65.

3. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740–56.

4. Holst JJ. From the incretin concept and the discovery of GLP-1 to today’s diabetes therapy. Front Endocrinol. 2019;10:260.

5. Deacon CF, Nauck MA, Toft-Nielsen M, et al. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes. 1995;44(9):1126–31.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-functional alpha-cell hyperplasia with glucagon-producing NET: a case report;Frontiers in Endocrinology;2024-09-06

2. GLP-1 receptor agonist-related risk of pancreatic cancer;Reactions Weekly;2023-04-08